Ventyx Biosciences, Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
VTYX Nasdaq 2830 ventyxbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Ventyx Biosciences, Inc.

Ventyx Provides Clinical and Corporate Updates - Dec 2nd, 2025 5:02 am
Ventyx Biosciences to Participate in the Piper Sandler 37th Annual Healthcare Conference - Dec 1st, 2025 5:02 am
With 57% ownership, Ventyx Biosciences, Inc. (NASDAQ:VTYX) boasts of strong institutional backing - Nov 24th, 2025 3:30 am
Ventyx Biosciences (VTYX) Outlook Strengthened by Cost Optimization and Positive Clinical Data - Nov 23rd, 2025 5:02 am
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference in London - Nov 17th, 2025 5:02 am
Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress - Nov 6th, 2025 2:02 pm
Ventyx Biosciences (VTYX): Assessing Valuation After Breakthrough Phase 2 Results for VTX3232 - Oct 27th, 2025 3:08 pm
Ventyx Biosciences Reports Positive Phase 2 Data for Oral NLRP3 Inhibitor VTX3232 in Obesity and Cardiovascular Risk - Oct 26th, 2025 4:43 am
Ventyx Biosciences (VTYX) Rethinks Anti-Inflammatory Pipeline After Promising Phase 2 Results for VTX3232 - Oct 25th, 2025 10:08 pm
Sector Update: Health Care Stocks Mixed Late Afternoon - Oct 23rd, 2025 1:55 pm
BC-Most Active Stocks - Oct 23rd, 2025 8:30 am
Tesla Earnings Dent Investor Sentiment, Driving Narrow Premarket Losses for US Equity Futures - Oct 23rd, 2025 7:13 am
Ventyx shares soar after study suggests cardiovascular benefits for experimental drug - Oct 23rd, 2025 5:36 am
Ventyx Biosciences Announces Positive Topline Results from Phase 2 Study of VTX3232 in Participants with Obesity and Cardiovascular Risk Factors - Oct 22nd, 2025 2:02 pm
Ventyx Biosciences, Inc. (VTYX) Is Up 20.81% in One Week: What You Should Know - Oct 9th, 2025 10:00 am
3 Penny Stocks With Market Caps Over $100M And Promising Growth - Sep 23rd, 2025 6:05 am
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences - Aug 27th, 2025 5:02 am
Ventyx Biosciences Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Progress - Aug 7th, 2025 2:05 pm
Top Penny Stocks To Watch In July 2025 - Jul 28th, 2025 6:05 am
Is Ventyx Biosciences (NASDAQ:VTYX) In A Good Position To Invest In Growth? - Jul 21st, 2025 12:43 pm